Provider Ranking · FDA Label–Verified · May 2026
Best GLP-1 Provider for People on Birth Control (2026)
Affiliate disclosure: Some links earn us a commission. Medical and safety facts override commercial preference, every time. See our methodology →
The best GLP-1 provider for people on birth control is Ro — $39 your first month for the Ro Body membership, then $149/month or as low as $74/month with annual prepay. Medication is billed separately, starting at $149/month for certain lower-dose oral options. Here is why we say that, and what would change the answer.
Ro publicly lists the key FDA-approved paths for this decision — Wegovy pill, Wegovy pen, Zepbound pen, Zepbound KwikPen, Foundayo, and Ozempic — checks your eligible GLP-1 insurance coverage for free, and is one of the only major telehealth platforms that publishes its own patient-facing guidance on tirzepatide and birth control.
But the right answer changes based on two things: your birth-control method, and which medication you start. If you use a non-oral method (IUD, implant, patch, ring, or Depo shot), the oral-absorption issue this whole page is about does not apply to you. If you use the pill, your medication choice is what matters most — and that is the part most pages get wrong.
What we actually verified for this page
We read the FDA prescribing labels for Zepbound, Mounjaro, Wegovy, Ozempic, and Foundayo directly on accessdata.fda.gov and DailyMed. We checked medication menus and current pricing for Ro, Eden, Sesame Care, MEDVi, and SHED on each provider's public pages on May 7, 2026. We pulled the pharmacology data from the Reproductive Health Access Project's contraceptive pearl on GLP-1 + oral contraceptives and from Skelley et al., Journal of the American Pharmacists Association, 2024.
We did not perform clinical testing or interview clinicians for this page. Provider recommendations are editorial conclusions based on verified facts and our scoring framework.
The Birth-Control Confidence Scorecard
Skip ahead if you already know your situation. Here is the verdict at a glance.
| Rank | Provider | Best for | Medications listed | Starting price | Honest reason not to choose |
|---|---|---|---|---|---|
| 1 | Ro | Pill users who want FDA-approved meds + insurance coverage check | Wegovy pill, Wegovy pen, Zepbound pen, Zepbound KwikPen, Foundayo, Ozempic | $39 first month, then $149/mo (or $74/mo annual prepay); medication billed separately | Not the cheapest cash-pay path |
| 2 | Eden | Pill users paying cash who want a semaglutide-first route | Compounded semaglutide and tirzepatide, plus branded Wegovy and Zepbound | Compounded semaglutide as low as $129 first month (3-month plan); no membership fee | Compounded medications are not FDA-approved as finished products |
| 3 | Sesame Care | Provider choice, video visits, labs, or Costco-member branded pricing | Wegovy pill, Wegovy pen, Zepbound KwikPen, Zepbound, Foundayo, Ozempic | Program from $59/mo annual; medication separate; Costco-member Wegovy $199/mo first 2 months | No published Sesame-specific birth-control GLP-1 guide verified |
| 4 | MEDVi | Budget-conscious users specifically seeking semaglutide-containing compounded prescriptions | Compounded semaglutide and compounded tirzepatide | $179 first month; $299 refills | Received a 2026 FDA warning letter on compounded GLP-1 marketing — disclosed in detail below |
| 5 | SHED | Needle-averse readers seeking compounded oral or sublingual options | Compounded injections, lozenges, and oral drops | Lozenges ~$199/mo; injectables from $299/mo | Compounded products are not FDA-approved or FDA-reviewed for safety, effectiveness, or quality |
Take birth control pills and want the clearest path?
Ro lists every FDA-approved GLP-1 you would consider here, checks your insurance coverage for free, and publishes its own guidance on tirzepatide and oral contraception.
Check your eligibility on Ro →Free insurance check · about 3 minutes · no commitment
Pick your starting point in 3 seconds
- On the pill, want the clearest FDA-approved path → start with Ro
- On the pill, paying cash → start with Eden
- On the pill, want lowest branded price (Costco member) → start with Sesame Care
- Use an IUD, implant, patch, ring, or Depo shot → choose any of the above by price and medication preference
- Want needle-free (drops or lozenges) → see SHED (after reading the contraception checklist below)
- Pregnant, possibly pregnant, or actively trying → do not start from this page — talk to your OB-GYN first
How birth control changes which GLP-1 is right for you
💊If you take the pill or minipill (combined or progestin-only)
- Easiest path: A semaglutide-based GLP-1 (Wegovy or Ozempic). Semaglutide does not carry the FDA oral-contraceptive warning.
- Doable path: Tirzepatide (Zepbound, Mounjaro) or Foundayo, with a barrier method for 4 weeks (tirzepatide) or 30 days (Foundayo) after starting and after every dose increase.
- Cleanest path: Switch to a non-oral method first, then start any GLP-1.
If you use a hormonal or copper IUD
No oral-absorption interaction. IUDs work locally inside your uterus. They do not depend on your stomach. Choose any GLP-1 based on price, support, and medication preference.
If you use the implant (Nexplanon)
No oral-absorption interaction. The implant releases hormone slowly under the skin in your arm. It bypasses the gut entirely.
If you use the patch (Xulane, Twirla, Zafemy)
No GLP-1 oral-absorption interaction. The hormone goes through your skin, not your stomach.
Separate caveat: the patch has body-weight effectiveness limits independent of GLP-1 use, including a contraindication at BMI ≥30 across all current U.S. patches.
If you use the vaginal ring (NuvaRing, Annovera) or Depo-Provera shot
No interaction. Vaginal and injectable methods are not affected by gastric emptying. For Depo: note its separate documented weight-gain side effect — worth discussing with your clinician if weight loss is your GLP-1 goal.
If you are not sure pregnancy is fully off the table
Stop here. Do not start a GLP-1 from this page. Talk to your prescribing clinician or OB-GYN about contraception first. That is the one bullet most affiliate pages do not say out loud.
Which GLP-1 medications affect birth control?
| Medication (brand) | Active ingredient | FDA birth-control warning? | What the label says | What it means in practice |
|---|---|---|---|---|
| Zepbound (weight loss) | Tirzepatide | Yes — explicit | Switch to non-oral or add barrier for 4 weeks after initiation and 4 weeks after each dose escalation. | After a single 5 mg dose, ethinyl estradiol Cmax dropped 59%, norgestimate Cmax dropped 66%. |
| Mounjaro (T2D) | Tirzepatide | Yes — explicit | Same warning, same molecule as Zepbound. | Same as Zepbound. |
| Foundayo (weight loss, FDA-approved Apr 1 2026) | Orforglipron | Yes — explicit | Switch to non-oral or add barrier for 30 days after initiation and 30 days after each dose escalation. | OC effect not directly tested but warning applies because Foundayo also delays gastric emptying. |
| Wegovy injection (weight loss) | Semaglutide | No specific OC warning | General "delays gastric emptying — may impact absorption of oral medications" language only. | Clinical study (Kapitza et al., 2015) found semaglutide did not reduce OC exposure. No FDA backup requirement. |
| Wegovy pill (weight loss) | Semaglutide | No specific OC warning | Same general language. Separate timing rule: take on empty stomach; wait 30 min before any other oral medication including the pill. | Take your birth-control pill 30+ minutes after the Wegovy pill. Timing instruction, not an interaction warning. |
| Ozempic (T2D) | Semaglutide | No specific OC warning | Same general language as Wegovy injection. | Same — no required backup. |
| Saxenda (weight loss) | Liraglutide | No | Did not affect oral contraceptive bioavailability in studies. | No backup needed. |
| Trulicity (T2D) | Dulaglutide | No | No effect on oral contraceptive bioavailability. | No backup needed. |
| Semaglutide-containing compounded prescription | Semaglutide-containing compounded drug | No separate FDA label | Compounded drugs are not FDA-approved or FDA-reviewed for safety, effectiveness, or quality. Do not assume equivalence to Wegovy or Ozempic. | Ask your prescriber what missed-pill rules apply to your specific prescription. |
| Tirzepatide-containing compounded prescription | Tirzepatide-containing compounded drug | No separate FDA label | Not FDA-approved. Do not assume equivalence to Zepbound or Mounjaro. | Because FDA-approved tirzepatide carries a 4-week backup rule, ask your prescriber whether the same window applies to your compounded prescription. |
Want the simplest path? Pick semaglutide from a provider with published birth-control guidance.
Both Ro and Eden publish their own guidance on GLP-1s and oral contraceptives. We rank them in that order because Ro lists every FDA-approved option and Eden specializes in the self-pay semaglutide route.
Best GLP-1 provider by contraceptive method
| Your contraceptive method | Affected by tirzepatide / Foundayo? | Affected by semaglutide? | Best first-look provider |
|---|---|---|---|
| Combined oral pill (estrogen + progestin) | Yes — backup needed | No specific FDA-labeled requirement | Ro (FDA-approved breadth) or Eden (self-pay semaglutide-first) |
| Progestin-only pill (minipill) | Yes — same labeled requirement | No specific FDA-labeled requirement | Same as above |
| Hormonal IUD (Mirena, Kyleena, Liletta, Skyla) | No | No | Ro, Eden, Sesame, or MEDVi — pick by price |
| Copper IUD (Paragard) | No | No | Same — pick by price |
| Etonogestrel implant (Nexplanon) | No | No | Same — pick by price |
| Contraceptive patch (Xulane, Twirla, Zafemy) | No (for GLP-1 oral-absorption issue) — but patches have separate BMI ≥30 contraindication | No | Same — pick by price; flag patch's weight limits with your clinician |
| Vaginal ring (NuvaRing, Annovera) | No | No | Same — pick by price |
| Depo-Provera shot | No | No | Same — pick by price; consider Depo's separate weight-gain side effect |
| Emergency contraception (Plan B, Ella) | Limited published data | Limited published data | Talk to your clinician or pharmacist; copper IUD is a non-oral emergency option |
| Pregnant, possibly pregnant, or actively trying | N/A | N/A | Do not start from this page. |
Birth-Control + GLP-1 Backup Window Tool
Use our free tool to generate a personalized backup-contraception calendar based on your specific situation — medication, contraceptive method, start date, and dose increases.
- Personalized backup calendar with specific dates you would need extra protection
- Printable list of questions to ask your provider
- Provider shortlist matched to your situation
Why Ro is our top pick for people on birth control pills
Verified on Ro's pages, May 7, 2026:
- Medication menu (publicly listed): Wegovy pill, Wegovy pen, Zepbound pen, Zepbound KwikPen, Foundayo, Ozempic
- Pricing match: Ro matches LillyDirect, NovoCare, and TrumpRx on certain medication prices
- Insurance: Free GLP-1 Insurance Coverage Checker; insurance concierge handles GLP-1 coverage paperwork
- Birth-control content: Ro publishes its own articles on Mounjaro/Zepbound + birth control AND Ozempic + birth control — neither Eden, Sesame, MEDVi, nor SHED match this combined breadth that we could verify
Who Ro is best for
- You take birth-control pills and want the clearest medication path
- You want FDA-approved medication only (no compounded)
- You have commercial insurance and want help with prior authorization
- You want the option to choose between semaglutide and tirzepatide
- You want Wegovy pill, Foundayo, or Zepbound KwikPen specifically
The honest reason not to choose Ro
Ro is not the cheapest cash-pay GLP-1 path. If you are paying out of pocket and your only goal is the lowest monthly price, Eden's compounded semaglutide ($129 first month on a 3-month plan) or MEDVi's intro pricing ($179 first month) will beat Ro on sticker.
The reason this page recommends Ro for pill users is medication clarity, not price. Ro skips compounded medications entirely, so there is never a question about what is in your pen.
If FDA-approved medication, free insurance coverage check, and a real birth-control protocol are what you need:
Why Eden is the best self-pay alternative
- Birth-control guide: Eden's guide explicitly distinguishes semaglutide from tirzepatide — exactly the right framing for a pill user.
- No membership fee. You pay for medication and visits, not a recurring subscription.
- Clear semaglutide path. If you want the medication that does not carry the FDA's oral-contraceptive warning, Eden makes that easy to choose.
- Branded options too. Branded Wegovy and Zepbound are available at higher prices.
Eden is best for
- On birth-control pills and paying cash
- Want the lower-cost semaglutide-first route
- Do not want a recurring membership fee
- Comfortable with compounded medications after reading the compounded section below
Eden is not best for
- You want insurance prior-auth handled for you (Ro is stronger here)
- You only want FDA-approved branded medication at the lowest price (Sesame is stronger)
- You are unsure about compounded — the FDA's posture on compounded GLP-1s is still evolving in 2026
When Sesame Care is the better fit
Sesame Costco/Novo offer (verified May 7, 2026; valid Nov 17, 2025 – Jun 30, 2026)
- Qualifying new self-pay Costco-member patients: $199/month for the first two months at the lowest Wegovy dose
- Then $349/month for Wegovy injections
- Ozempic $349/month (0.25–1 mg) and $499/month (2 mg)
- Medication cost is separate from Sesame subscription
- You pick the clinician. Sesame is a marketplace; you book the prescriber you want.
- Labs and video visits included. Quest lab work included in most states (excludes AZ, HI, ND, NJ, NY, OK, RI, SD, WY).
- FDA-approved menu: Wegovy pill, Wegovy pen, Zepbound KwikPen, Zepbound, Foundayo, Ozempic.
- No published Sesame-specific birth-control GLP-1 guide that we found. If birth-control guidance from the platform itself matters to you, Ro is stronger here.
MEDVi — for compounded prescriptions (with full FDA letter context)
Read this before clicking
In February 2026, the FDA issued a warning letter to MEDVi citing false or misleading promotional and labeling claims, including product-source claims and "same active ingredient" claims that the FDA said could imply FDA approval or FDA evaluation of safety and effectiveness that had not occurred. MEDVi published a response disputing the framing and saying its marketing practices have been updated. We are disclosing this because you deserve to know it before clicking.
MEDVi is best for
- Paying cash and want low first-month price on compounded semaglutide
- On a non-oral contraceptive (the oral-absorption question does not apply)
- Have read the FDA warning letter context above and are comfortable proceeding
MEDVi is not best for
- You want FDA-approved branded medication (Ro or Sesame)
- You want insurance support (Ro)
- You want a provider that has published its own birth-control guidance (Ro or Eden)
SHED — for needle-free seekers (cautious recommendation)
Two reasons SHED is not our first recommendation for pill users:
- Needle-free formulation does not change the active-ingredient interaction question. A tirzepatide-containing compounded lozenge raises the same contraception question as a tirzepatide-containing injection.
- FDA-approved label clarity is not there. Compounded products are not FDA-evaluated as finished products, so the contraception language on FDA-approved drug labels does not automatically apply to your prescription.
SHED is best for:
- You are firmly needle-averse
- You have already chosen your contraceptive plan with a clinician
- You understand the compounded caveats
If oral or sublingual GLP-1s are non-negotiable, use the 9-question checklist below before clicking through to SHED.
See SHED's needle-free options →How much does each GLP-1 provider cost after the first month?
Most provider pricing pages lead with intro offers. The number that actually matters is what you pay starting in month two. Below is what we verified on May 7, 2026.
| Provider | Membership / program fee | Medication included? | Lowest verified medication price | After-intro price | Promo / refill condition |
|---|---|---|---|---|---|
| Ro | $39 first month, then $149/month, or ~$74/month annual prepay | No — billed separately | Foundayo from $149/month at lowest dose | $149/month membership + medication | Annual prepay reduces effective monthly to ~$74 |
| Eden | None | Medication price is the program | Compounded semaglutide as low as $129 first month (3-month plan) | Tied to the multi-month plan you choose | Branded Wegovy and Zepbound are higher |
| Sesame Care | From $59/month annual; pay-per-visit also available | No — billed separately | Costco-member $199/month Wegovy first 2 months | $349/month Wegovy after intro | Costco offer valid Nov 17, 2025 – Jun 30, 2026 |
| MEDVi | None (medication-bundled pricing) | Medication price is the program | $179 first month | $299/month refills | Standard refill cadence |
| SHED | None (medication-bundled pricing) | Medication price is the program | Lozenges from ~$199/month | Same — no separate intro | Pricing varies by formulation and dose |
Tirzepatide on the pill — the practical playbook
| Week | Tirzepatide dose | Backup contraception needed? |
|---|---|---|
| 1–4 | 2.5 mg | Yes — first 4 weeks after starting |
| 5–8 | 5 mg (first dose escalation) | Yes — 4 weeks after escalation |
| 9–12 | Still 5 mg | Not specifically required by label |
| 13–16 | 7.5 mg (second escalation) | Yes — 4 weeks after escalation |
| 17–20 | Still 7.5 mg | Not specifically required by label |
| 21–24 | 10 mg (third escalation) | Yes — 4 weeks after escalation |
| 25+ | Continue titration to 12.5 mg, then 15 mg | Yes during each new escalation window |
If your clinician follows the standard titration cadence, you will be in a "backup needed" window for roughly the first six months of tirzepatide use. That is a real ask.
This is why some pill users decide to either: (1) choose semaglutide instead (no backup window required), or (2) switch to a non-oral contraceptive method first.
If you want tirzepatide specifically, Ro is the strongest provider fit because Ro publishes its own Mounjaro/Zepbound birth-control article and the insurance concierge can help you navigate medication coverage.
Start the Ro Body eligibility check →Semaglutide on the pill — what to know
What this means: semaglutide has not been shown to reduce combined oral-contraceptive levels, and it does not carry the FDA's tirzepatide/Foundayo backup-contraception requirement. Vomiting, diarrhea, missed pills, or timing errors can still affect your protection — those are method-of-use issues, not medication interactions.
For pill users, semaglutide is the medication-level path of least resistance. Strongest provider matches:
Foundayo on the pill — the 30-day rule
Foundayo is the first oral non-peptide GLP-1 — genuinely new. Its FDA label is honest about what is known and not known: the effect of Foundayo on oral contraceptive absorption has not been directly tested in a clinical trial. The label applies the precautionary recommendation because Foundayo also delays gastric emptying.
Foundayo is available through Ro, Hers, and Sesame Care among the major telehealth platforms as of April–May 2026. Ro lists Foundayo at a starting cash price of $149/month for the lowest dose (membership separate).
Foundayo on Ro — check eligibility →Non-oral contraception with GLP-1s — what changes
Hormonal IUDs (Mirena, Kyleena, Liletta, Skyla)
Localized hormone delivery in the uterus. Not affected by gastric emptying.
Copper IUD (Paragard)
Non-hormonal, mechanical action. Copper is toxic to sperm. Not affected by anything you swallow.
Etonogestrel implant (Nexplanon)
Subcutaneous rod in the upper arm. Releases hormone over 3 years. Not affected by GI absorption.
Contraceptive patch (Xulane, Twirla, Zafemy)
Transdermal hormone delivery. Not affected by GLP-1s.
Separate caveat: Xulane and Zafemy may be less effective at 198 lb (90 kg) or more and are contraindicated at BMI ≥30. Twirla has reduced effectiveness at BMI ≥25 to <30 and is contraindicated at BMI ≥30. This is independent of GLP-1 use but worth flagging because this audience often has a higher starting BMI.
Vaginal ring (NuvaRing, Annovera)
Vaginal absorption. Not affected by gastric emptying.
Depo-Provera shot (DMPA)
Intramuscular injection every 3 months. Not affected by gastric emptying.
Separate caveat: Depo carries a documented weight-gain side effect of its own. If your reason for starting a GLP-1 is weight loss, talk to your clinician about whether Depo is the right long-term contraceptive for you.
What to do if you get vomiting or diarrhea on a GLP-1
FDA-approved vs compounded — what changes for pill users
Semaglutide-containing compounded prescription
Not FDA-approved as a finished product. The published semaglutide oral-contraceptive evidence applies to FDA-approved Wegovy and Ozempic, not automatically to your compounded prescription. Ask your prescriber what missed-pill rules they want you to follow.
Tirzepatide-containing compounded prescription
Not FDA-approved as a finished product. Because FDA-approved tirzepatide carries a 4-week oral-contraceptive backup rule, ask your prescriber whether to follow that same window for your compounded prescription.
2026 regulatory context
The FDA has clarified that compounded drugs are not FDA-approved, are not generics, and that semaglutide and tirzepatide do not currently appear on the FDA shortage list. On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list — meaning the regulatory window for routine 503B compounding of these molecules is narrowing.
The 9 questions to ask any GLP-1 provider before you start
Am I being prescribed semaglutide, tirzepatide, or orforglipron? Different molecules, different interaction profiles.
Is this an FDA-approved medication or a compounded prescription? Affects label clarity and the counseling you should get.
If I take birth-control pills, do I need backup contraception? Yes for FDA-approved tirzepatide and Foundayo. No FDA-labeled requirement for semaglutide.
Does the backup window repeat after every dose increase? Yes for FDA-approved tirzepatide and Foundayo.
What should I do if I vomit or have diarrhea after taking my pill? Standard missed-pill rules apply; CDC guidance is 48 hours of continuous symptoms triggers backup contraception.
Should I switch to a non-oral method before starting? One of the FDA's two label-recommended options for tirzepatide and Foundayo users.
What happens if I become pregnant or think I might be pregnant? Stop the medication and contact your clinician immediately.
Who do I message if side effects make my oral medication unreliable? Provider responsiveness matters; ask before you pay.
Can I see the pharmacy or source and the cancellation terms before I pay? Transparent providers will share both.
Not sure which provider fits your answers?
Take our free 60-second matching quiz — answer six questions and we will show you exactly which provider to start with and why.
Find my GLP-1 path (60-second quiz) → No email requiredHow we ranked these providers
| Category | Weight | Why it matters |
|---|---|---|
| Birth-control-specific clarity | 30% | This is the search friction. Provider should already understand it. |
| FDA-approved medication access | 20% | Labels give the clearest contraception language. |
| Support and messaging model | 15% | Side effects and dose changes need real-time help. |
| Pricing transparency | 15% | Surprise charges break trust. |
| Insurance / prior-auth help | 10% | Critical for branded GLP-1s. |
| Regulatory and trust signals | 10% | YMYL pages must disclose enforcement actions and limitations. |
When NOT to start a GLP-1 from this page
If you are pregnant, possibly pregnant, or actively trying to conceive, do not start a GLP-1 from this page. Talk to your OB-GYN, prescribing clinician, or reproductive endocrinologist first.
GLP-1 + Birth Control FAQ
Still not sure which GLP-1 program is right for you?
Take our free 60-second matching quiz. Answer six questions about your contraceptive method, medication preferences, and budget — we will show you exactly which provider to start with and why.
Find my GLP-1 path (60-second quiz) →No email requiredAbout this page
Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We earn a commission on certain links and disclose every affiliate relationship. Recommendations are based on our published scoring framework and are not paid placements.
This page is for information only and is not medical advice. Starting, stopping, or switching medication or contraception should be decided with a licensed clinician, pharmacist, OB-GYN, or reproductive-health professional.
Last verified: . We re-verify pricing, medication menus, and FDA label currency on a quarterly cadence — sooner if there is a meaningful regulatory or label update.
Sources cited on this page
- FDA Zepbound prescribing information (accessdata.fda.gov)
- FDA Mounjaro prescribing information (accessdata.fda.gov)
- FDA Wegovy injection and Wegovy pill prescribing information (accessdata.fda.gov)
- FDA Ozempic prescribing information (accessdata.fda.gov)
- DailyMed Foundayo (orforglipron) prescribing information (dailymed.nlm.nih.gov)
- FDA Warning Letter to MEDVi, LLC (February 20, 2026), fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters
- FDA, "Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize" (2026), fda.gov/drugs/drug-alerts-and-statements
- Reproductive Health Access Project Contraceptive Pearl on GLP-1 + oral contraceptives (reproductiveaccess.org)
- Skelley JW et al., Journal of the American Pharmacists Association, 2024 — review of tirzepatide and GLP-1 RAs on oral hormonal contraception
- Kapitza C et al., Journal of Clinical Pharmacology, 2015 — semaglutide + ethinylestradiol/levonorgestrel pharmacokinetic study
- Provider verification (May 7, 2026): ro.co/weight-loss, tryeden.com/weight-loss, sesamecare.com, glp.medvi.org, tryshed.com
- DailyMed prescribing information for Xulane, Twirla, and Zafemy (BMI labeling)
- U.S. CDC summary guidance on missed combined oral contraceptive pills with continuous vomiting/diarrhea ≥48 hours